chartexchange

Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (MDGL) and Encourages Investors Who Suffered Losses to Contact the Firm

Newsfile | Nov 13, 2026 1:00 PM EST

New York, New York--(Newsfile Corp. - November 13, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Madrigal investor and have suffered losses, or if you have information that could assist in the Madrigal investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing...

Read original article